ASAP1 Promotes Epithelial to Mesenchymal Transition by Activating the TGFβ Pathway in Papillary Thyroid Cancer
Cancer Medicine · 2025-08 · 14 (15)
DOI: 10.1002/cam4.71075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 31.07.2025. Verfasst von Shiji Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, People's Republic of China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Transforming Growth Factor beta, Thyroid Cancer, Papillary, Thyroid Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young and middle-aged Health Science and Technology Innovation Talent of Henan Province.
Abstract (Originalsprache)
Background
Papillary thyroid cancer (PTC) is the most common type of thyroid malignancy. While the prognosis of PTC is generally favorable, some cases exhibit aggressive behavior, leading to metastasis and recurrence. ASAP1 (ArfGAP with SH3, ankyrin repeats, and PH domain 1), an ADP‐ribosylation factor GTPase‐activating protein, has been implicated in tumor metastasis. However, its role in PTC remains unclear.
Methods
ASAP1 expression in PTC was evaluated using TCGA and GEO databases. Studies in PTC cell lines (MDA‐T32 and MDA‐T85) included lentiviral‐mediated knockdown and overexpression of ASAP1 to assess effects on epithelial–mesenchymal transition (EMT) marker expression, cell proliferation, and invasive capacity. TGFβ pathway activity was examined by p‐SMAD2 Western blotting and luciferase reporter assays. ASAP1‐SMAD2/3 interactions were analyzed using co‐immunoprecipitation (CO‐IP) and immunofluorescence.
Results
ASAP1 was aberrantly upregulated in PTC. Lentiviral knockdown of ASAP1 in PTC cells suppressed the EMT process. Reduced ASAP1 expression also inhibited cell survival, proliferation, migration, invasion, and the expression of p‐SMAD2 in the TGFβ pathway in PTC cells. Conversely, ASAP1 overexpression reversed these effects. Mechanistically, ASAP1 interacts with the SMAD2/3 complex, forming a positive feedback loop with TGFβ signaling that promotes EMT and cell invasiveness in PTC cells, which suggests its potential role in PTC metastasis.
Conclusions
These findings suggest that targeting ASAP1 may offer a novel therapeutic strategy to limit PTC metastasis by suppressing EMT and attenuating the TGFβ pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
- Department of Gynecology and Obstetrics, The Third Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
- Department of Pathology and Laboratory Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
ORCID-Profile: Yuxia Fan
Förderung
- Young and middle-aged Health Science and Technology Innovation Talent of Henan Province
Zitieren
APA
Song, S., Leng, Z., Zhao, X., Liu, Z., Li, Y., Zhang, W., Yue, J., & Fan, Y. (2025). ASAP1 Promotes Epithelial to Mesenchymal Transition by Activating the TGFβ Pathway in Papillary Thyroid Cancer. Cancer Medicine, 14(15). https://doi.org/10.1002/cam4.71075
Vancouver
Song S, Leng Z, Zhao X, Liu Z, Li Y, Zhang W, et al. ASAP1 Promotes Epithelial to Mesenchymal Transition by Activating the TGFβ Pathway in Papillary Thyroid Cancer. Cancer Medicine. 2025;14(15). doi:10.1002/cam4.71075
BibTeX
@article{Song2025,
author = {Song, Shiji and Leng, Zixing and Zhao, Xinxin and Liu, Ziping and Li, Yongshuai and Zhang, Wenjing and Yue, Junming and Fan, Yuxia},
title = {ASAP1 Promotes Epithelial to Mesenchymal Transition by Activating the TGFβ Pathway in Papillary Thyroid Cancer},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {15},
doi = {10.1002/cam4.71075}
}
EUVIMED